Skip to main content

Relay Therapeutics, Inc.

RLAY
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001812364

In the last 90 days, Relay Therapeutics, Inc. insiders filed 0 open-market purchases and 13 sales; 259 institutions reported holding it in 13F filings for Q2 2026, worth $4.58B in total; Duquesne Family Office is the only superinvestor holding it.

Q1 2025 vs. Q4 2024

How the institutions holding Relay Therapeutics, Inc. changed between Q4 2024 and Q1 2025.

All holders in Q1 2025All holders in Q4 2024

13F holders of RLAY: Q4 2024 compared with Q1 2025
MeasureQ4 2024Of which not filed for Q1 2025Q1 2025Change
Holders2004208+12
Shares163.9M4.69M167.3M+8.03M (+5.0%)
Value$675.8M$19.3M$438.1M−$218.3M (−33.3%)

4 institutions that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so the changes leave them out.

New holders (36)

Institutions that held Relay Therapeutics, Inc. at the end of Q1 2025 but not at the end of Q4 2024.

Institutions new to RLAY in Q1 2025
InstitutionSharesValue% of portfolio
Nextech Invest, Ltd.3,846,409$10.1M2.34%
Polygon Management Ltd.619,000$1.62M0.52%
Dark Forest Capital Management LP405,995$1.06M0.05%
HRT Financial LP368,579$965.0K0.01%
Nuveen, LLC320,395$839.4K0.00%
Congress Wealth Management LLC186,063$487.5K0.01%
Private Capital Advisors, Inc.100,000$262.0K0.03%
Omers Administration Corp85,200$223.2K0.00%
Point72 Asia (Singapore) Pte. Ltd.71,649$187.7K0.05%
Polymer Capital Management (US) LLC69,404$181.8K0.05%
Ieq Capital, LLC56,334$147.6K0.00%
Brevan Howard Capital Management LP46,548$122.0K0.00%
Jain Global LLC43,735$114.6K0.00%
Virtus Investment Advisers, Inc.34,345$90.0K0.02%
Bank of Montreal31,778$83.3K0.00%
Engineers Gate Manager LP29,438$77.1K0.00%
Cresset Asset Management, LLC29,379$77.0K0.00%
Arkadios Wealth Advisors25,669$67.3K0.00%
SEI Investments Co25,630$67.2K0.00%
Dynamic Technology Lab Private Ltd20,067$53.0K0.01%
Wealth Enhancement Advisory Services, LLC15,472$40.5K0.00%
Quantessence Capital LLC12,650$33.1K0.01%
AssuredPartners Investment Advisors, LLC11,229$29.4K0.01%
DRW Securities, LLC10,757$28.2K0.00%
Catalyst Funds Management Pty Ltd10,100$26.5K0.01%
Murchinson Ltd.10,000$26.2K0.00%
FNY Investment Advisers, LLC5,000$13.0K0.01%
Point72 (DIFC) Ltd4,663$12.2K0.00%
Lindbrook Capital, LLC2,195$5.75K0.00%
Versant Capital Management, Inc1,458$3.82K0.00%
Coldstream Capital Management Inc341$8940.00%
Hughes Financial Services, LLC308$7610.00%
Jones Financial Companies LLLP154$4190.00%
Parkside Financial Bank & Trust125$3270.00%
Parallel Advisors, LLC74$1940.00%
Massmutual Trust Co FSB28$730.00%

Sold out (24)

Institutions that held Relay Therapeutics, Inc. at the end of Q4 2024 and filed for Q1 2025 without it.

Not filed for Q1 2025 yet (4)

Institutions that held Relay Therapeutics, Inc. at the end of Q4 2024 and haven't filed a 13F for Q1 2025. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding RLAY in Q4 2024 that haven't filed for Q1 2025
InstitutionShares, Q4 2024Value, Q4 2024
Nextech Invest AG3,846,409$15.8M
Nuveen Asset Management, LLC653,428$2.69M
Fernwood Investment Management, LLC185,763$765.3K
Global Retirement Partners, LLC562$2.31K